TPM4 acts as a potential predictor for the response to PD-1/PD-L1-inhibitor therapy in patients with glioblastoma

oleh: Lirui Dai, Mahbub E Touhid, Peizhi Zhou, Shu Jiang

Format: Article
Diterbitkan: Elsevier 2024-08-01

Deskripsi

Subjek

TPM4; Glioblastoma; Immunotherapy; Biomarker